News

WHO Extended Global Emergency Status of MPox Epidemic – Development of Treatment for MPox with NV-387 is Timely, Says NanoViricides
SHELTON, CONNECTICUT / ACCESS Newswire / July 16, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) ...
Call for RSV vaccine subsidies for elderly as severe hospitalisations on rise
RSV has outstripped severe Covid and flu hospitalisation rates and proved itself more fatal than either of the flu season ...
Vietnam Investment Review15h
ArkBio's RSV Drug Added to WHO Pediatric Priority List
Ziresovir earns global recognition, boosting hope for young RSV patients and strengthening ArkBio’s innovative pipeline.
ArkBio's Ziresovir Included into Pediatric RSV Drug Priority List by WHO
In the newly released "Paediatric drug optimization for respiratory syncytial virus (PADO-RSV) meeting report" by Global ...
Verywell Health23h
Not Enough Adults Are Getting the RSV Vaccine. Here's Why That Matters
“Appropriate people at higher risk should be vaccinated, and this will not only benefit the vaccinated person, but will ...